CNN — Results from a study investigating Gilead Sciences’ antiviral medication remdesivir as a Covid-19 treatment were posted to the World Health Organization’s website “prematurely” on Thursday and showed “inconclusive” results, according to the biotechnology company. “Today, information from the first clinical study evaluating the investigational antiviral remdesivir in patients with severe Covid-19 disease in China was prematurely posted on …
